Defect of Adaptation to Hypoxia in Patients With COPD Due to Reduction of Histone Deacetylase 7

Defect of Adaptation to Hypoxia in Patients With COPD Due to Reduction of Histone Deacetylase 7

Bibliographic Details
Main Authors:	To, Masako, Yamamura, Satoshi, Akashi, Kenichi, Charron, Catherine E., Barnes, Peter J., Ito, Kazuhiro
Format:	Online
Language:	English
Published:	American College of Chest Physicians 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342783/

Similar Items

Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages
by: Cosio, Borja G., et al.
Published: (2004)

Passive Smoking Impairs Histone Deacetylase-2 in Children With Severe Asthma
by: Kobayashi, Yoshiki, et al.
Published: (2014)

Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression
by: Ito, Kazuhiro, et al.
Published: (2006)

Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD
by: Footitt, Joseph, et al.
Published: (2016)

Histone deacetylase activity is decreased in peripheral blood monocytes in patients with COPD
by: Chen, Yanwei, et al.
Published: (2012)

Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress
by: Mercado, Nicolas, et al.
Published: (2011)

Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer
by: Alzoubi, Samer, et al.
Published: (2016)

Reduced HDAC2 in skeletal muscle of COPD patients
by: Masako To, et al.
Published: (2017-05-01)

Histone deacetylases in viral infections
by: Herbein, Georges, et al.
Published: (2010)

Butyrate Histone Deacetylase Inhibitors
by: Steliou, Kosta, et al.
Published: (2012)

Histone deacetylase signaling in cardioprotection
by: Lehmann, Lorenz H., et al.
Published: (2013)

Histone deacetylase 6 in cancer
by: Ting Li, et al.
Published: (2018-09-01)

Butyrate Histone Deacetylase Inhibitors
by: Kosta Steliou, et al.
Published: (2012-08-01)

Histone deacetylase inhibitors in multiple myeloma
by: Deleu, Sarah, et al.
Published: (2009)

Targeting histone deacetylases for the treatment of disease
by: Lawless, M W, et al.
Published: (2009)

Clinical Toxicities of Histone Deacetylase Inhibitors
by: Subramanian, Srividya, et al.
Published: (2010)

Histone Deacetylases and Their Inhibition in Candida Species
by: Garnaud, Cécile, et al.
Published: (2016)

Acetylation and Histone Deacetylase Inhibitors in Cancer
by: Kortenhorst, Madeleine S. Q., et al.
Published: (2006)

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
by: Yan, Wensheng, et al.
Published: (2012)

Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
by: Huang, Ying, et al.
Published: (2011)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
by: Lapierre, Marion, et al.
Published: (2016)

Changes in Airway Histone Deacetylase2 in Smokers and COPD with Inhaled Corticosteroids: A Randomized Controlled Trial
by: Sohal, Sukhwinder Singh, et al.
Published: (2013)

Lymphocyte senescence in COPD is associated with decreased histone deacetylase 2 expression by pro-inflammatory lymphocytes
by: Hodge, Greg, et al.
Published: (2015)

Decreased Histone Deacetylase 2 (HDAC2) in Peripheral Blood Monocytes (PBMCs) of COPD Patients
by: Tan, Chunting, et al.
Published: (2016)

Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma
by: Saelen, Marie Grøn, et al.
Published: (2012)

Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
by: Jonsson, Marte, et al.
Published: (2016)

Irisin Ameliorates Hypoxia/Reoxygenation-Induced Injury through Modulation of Histone Deacetylase 4
by: Zhao, Yu Tina, et al.
Published: (2016)

Impaired histone deacetylases 5 and 6 expression mimics the effects of obesity and hypoxia on adipocyte function
by: Bricambert, Julien, et al.
Published: (2016)

The Histone Deacetylase Inhibitor, Vorinostat, Represses Hypoxia Inducible Factor 1 Alpha Expression through Translational Inhibition
by: Hutt, Darren M., et al.
Published: (2014)

Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy
by: Haery, Leila, et al.
Published: (2015)

Limited proteolysis of human histone deacetylase 1
by: Kamath, Nayana, et al.
Published: (2006)

Enhancing the anti-angiogenic action of histone deacetylase inhibitors
by: Kuljaca, Selena, et al.
Published: (2007)

Histone Deacetylase Complexes Promote Trinucleotide Repeat Expansions
by: Debacker, Kim, et al.
Published: (2012)

Histone deacetylase inhibitors: clinical implications for hematological malignancies
by: Tambaro, Francesco Paolo, et al.
Published: (2010)

Targeting Huntington’s disease through histone deacetylases
by: Gray, Steven G.
Published: (2011)

Regulation of Immune Responses by Histone Deacetylase Inhibitors
by: Licciardi, Paul V., et al.
Published: (2012)

Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?
by: Stintzing, Sebastian, et al.
Published: (2011)

Interpreting clinical assays for histone deacetylase inhibitors
by: Martinet, Nadine, et al.
Published: (2011)

Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming
by: Kretsovali, Androniki, et al.
Published: (2012)

Histone deacetylase complexes as caretakers of genome stability
by: Lahue, Robert, et al.
Published: (2012)